Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App





SARSTEDT Demonstrates Pre-Analytic Innovations for Improving Specimen Quality, Reducing TAT and Automating Labs

By LabMedica International staff writers
Posted on 26 Jul 2023

SARSTEDT (Nümbrecht, Germany), a leader in pre-analytic innovation, is demonstrating its solutions for improving specimen quality, reducing turnaround time, and automating labs of all sizes with customizable modular systems at AACC 2023. More...

The company’s pre-analytical experts are leading short in-booth workflow walkthroughs at the SARSTEDT booth.

SARSTEDT is also hosting an industry workshop where Dr. Mark Kellogg, Associate Director of Chemistry at Boston Children’s Hospital (Boston, MA, USA) will be presenting on maximizing pediatric laboratory efficiency through automation and improved quality small-volume S-Monovette® primary tubes. Dr. Kellogg will be discussing improving sample rejection rates by reducing hemolysis, clotting, and improper labeling, as well as integrating the S-Monovette® into a total laboratory automation process.

Visitors to the SARSTEDT booth can also check out the lighted tubes traveling overhead. On display is the SARSTEDT Tempus600®, a dedicated transportation system for sending specimen tubes quickly and reliably to the laboratory without batching or packing them into carriers. Sample tubes arrive within seconds at a laboratory receiving station for immediate processing. Samples arrive continuously as sent, reducing peaks for a faster and more predictable workflow. SARSTEDT will be demonstrating how the Tempus600® and IVD systems such as the Roche cobas® connection modules work together to shorten the time between tests being ordered and results being ready. Visitors can watch as blood collection tubes leave the SARSTEDT booth and arrive at the Roche booth in seconds.

Related Links:
SARSTEDT 
Boston Children’s Hospital 


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The patented biosensor measures enzymatic activity associated with inflammatory disease (Photo courtesy of Hawkeye Bio)

Non-Invasive and Radiation-Free Diagnostic Identifies Early-Stage Lung Cancer Across All Subtypes

Lung cancer remains the leading cause of cancer-related deaths, with nearly 125,000 deaths and 227,000 new cases estimated in the U.S. for 2025. Despite evidence showing that early detection significantly... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.